Powered by

Powered by Portfolio Grader

Direxion S&P Biotech Bull 3X (LABU)

52.85 2.89 (5.78%) 19:59 EST
LABU Stock Quote Delayed 15 Minutes
  • LABU Stock Chart

  • Historical LABU Prices

 
Dividend & Yield:       0.11 (0.22%)
P/E:       -
Market Cap:       227.87M
EPS:       -
Volume:       2.09M
Day's Range:       49.76 - 53.06
52wk Range:       24.00 - 116.12
Quotes delayed at least 20 mins.
Historical Data for LABU
Date Open High Low Volume Close Change %
02/22/19 50.68 53.06 49.76 2,091,535 52.85 2.89   5.78%
02/21/19 51.75 52.08 48.93 1,928,697 49.96 -2.26   -4.33%
02/20/19 52.90 53.97 49.75 2,354,206 52.22 -0.66   -1.25%
02/19/19 54.81 55.98 52.69 2,651,642 52.88 -1.77   -3.24%
02/15/19 51.77 54.66 51.40 2,333,500 54.65 3.29   6.41%
02/14/19 49.97 51.83 49.64 1,463,698 51.36 0.59   1.16%
02/13/19 51.42 52.28 50.56 1,889,936 50.77 -0.02   -0.04%
02/12/19 49.72 50.94 49.30 2,167,454 50.79 2.33   4.81%
02/11/19 48.51 48.84 46.96 1,467,791 48.46 0.69   1.44%
02/08/19 45.53 48.07 45.37 1,784,000 47.77 1.16   2.49%
02/07/19 49.54 50.39 45.57 2,834,549 46.61 -4.13   -8.14%
02/06/19 50.15 51.71 48.41 1,928,052 50.74 0.77   1.54%
02/05/19 50.90 53.33 49.00 2,978,852 49.97 -0.98   -1.92%
02/04/19 50.26 51.00 49.06 1,695,546 50.95 0.69   1.37%
02/01/19 49.39 50.78 48.20 2,572,900 50.26 0.67   1.35%
01/31/19 46.62 49.78 46.62 2,764,792 49.59 2.22   4.69%
01/30/19 44.68 47.44 43.22 3,331,038 47.37 3.59   8.20%
01/29/19 44.42 44.46 42.55 2,531,632 43.78 0.14   0.32%
01/28/19 45.40 45.82 43.36 3,490,890 43.64 -4.04   -8.47%
01/25/19 45.71 47.82 44.32 3,639,200 47.68 2.95   6.60%
01/24/19 43.43 44.75 42.85 2,671,947 44.73 1.23   2.83%
01/23/19 46.12 46.75 41.54 4,724,424 43.50 -1.76   -3.89%
01/22/19 48.50 48.75 44.34 5,631,704 45.26 -4.51   -9.06%
01/18/19 49.21 49.83 46.75 3,303,800 49.77 1.47   3.04%
01/17/19 46.51 49.39 46.26 2,592,430 48.30 1.13   2.40%
01/16/19 48.14 50.85 46.92 3,702,235 47.17 -0.54   -1.13%
01/15/19 44.99 47.74 44.44 3,183,112 47.71 3.19   7.17%
01/14/19 46.12 46.98 44.20 3,989,572 44.52 -3.18   -6.67%
01/11/19 47.41 48.26 46.27 2,611,100 47.70 -0.07   -0.15%
01/10/19 44.47 48.08 42.73 4,463,384 47.77 2.19   4.80%
01/09/19 45.81 46.93 44.81 3,211,279 45.58 0.44   0.97%
01/08/19 45.16 45.93 41.24 6,403,844 45.14 1.54   3.53%
01/07/19 39.50 44.00 39.46 5,338,259 43.60 6.59   17.81%
01/04/19 33.31 37.19 33.04 6,815,300 37.01 5.28   16.64%
01/03/19 34.40 35.10 31.60 6,447,054 31.73 -2.45   -7.17%
01/02/19 31.01 34.19 30.47 5,770,686 34.18 1.32   4.02%
12/31/18 31.66 32.95 31.10 6,093,900 32.86 2.36   7.74%
12/28/18 30.00 32.46 29.09 7,156,500 30.50 0.65   2.18%
12/27/18 29.09 30.49 26.27 7,817,697 29.85 -0.94   -3.05%
12/26/18 26.30 31.00 25.98 9,807,026 30.79 5.58   22.13%
12/24/18 24.44 26.94 24.00 6,201,900 25.21 -0.34   -1.33%
12/21/18 29.83 29.99 25.21 8,674,600 25.55 -3.80   -12.95%
12/20/18 32.18 32.97 28.05 9,786,830 29.35 -3.59   -10.90%
12/19/18 36.62 38.95 31.41 6,170,111 32.94 -3.67   -10.02%
12/18/18 39.88 40.23 34.76 6,167,312 36.61 -2.16   -5.57%
12/17/18 40.85 43.40 38.10 5,352,375 38.77 -2.86   -6.87%
12/14/18 42.20 43.92 41.08 3,485,300 41.63 -1.84   -4.23%
12/13/18 47.85 48.34 43.20 4,473,343 43.47 -3.92   -8.27%
12/12/18 46.91 48.86 46.48 2,912,791 47.39 1.99   4.38%
12/11/18 47.44 48.05 43.83 3,838,298 45.40 -0.48   -1.05%
12/10/18 43.88 46.38 41.55 4,003,689 45.88 1.69   3.82%
12/07/18 48.66 50.06 43.46 4,749,500 44.19 -4.63   -9.48%
12/06/18 45.85 49.15 44.50 4,635,274 48.82 0.50   1.03%
12/04/18 55.64 58.19 47.96 4,776,600 48.32 -8.64   -15.17%
Direxion S&P Biotech Bull 3X (LABU) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Direxion S&P Biotech Bull 3X Stock Analysis

Rating:

Total Grade:

Analysis Breakdown

LABU Stock Grade:
Fundamental Grade:
Quantitative Grade:
LABU Earnings
Earnings Growth:
Earnings Momentum:
Earnings Surprises:
Analyst Earnings Revisions:
LABU Financial Information
Sales Growth:
Operating Margin Growth:
Cash Flow:
Return on Equity:

Direxion S&P Biotech Bull 3X Stock: Weekly View

This Week:
Last Week:
Two Weeks Ago:
Get Full Report